Dan Ressler

Dan is the Life Sciences and Healthcare leader for Global Risk Advisory. He is also a principal in Deloitte Risk and Financial Advisory’s Life Sciences practice, serving as the US Advisory Life Sciences leader. With nearly 25 years of consulting experience in biopharmaceutical R&D, his experience includes capability strategy, complex delivery program leadership, tech integration, post-merger integration, global operating model design, and internal/external sourcing strategies. He has worked with large global pharmaceutical companies, mid-sized biotechs, academic medical research, and medical device companies.